solid tumors - Robuta Search

https://www.a2bio.com/ Innovating New Treatments for Solid Tumors | A2 Biotherapeutics Jun 23, 2026 - A2 is dedicated to advancing cancer treatment through pioneering cell therapy. Our T cells target solid tumors with precision, transforming the future of... new treatments solid tumors innovating biotherapeutics https://www.sciencedaily.com/releases/2014/08/140811151123.htm Novel drug action against solid tumors explained | ScienceDaily Researchers have discovered how a drug that deprives the cells of a key amino acid specifically kills cancer cells. The study describes how arginine starvation... solid tumors novel drug action explained https://www.cms.gov/medicare-coverage-database/view/nca.aspx?ncaid=218 NCA - Positron Emission Tomography (FDG) for Solid Tumors (CAG-00181R) Use this page to view details for NCA - Positron Emission Tomography (FDG) for Solid Tumors (CAG-00181R). positron emission tomography solid tumors nca fdg cag https://dispatchbio.com/ Immunotherapy for Solid Tumors: Dispatch Biotherapeutics Learn how Dispatch Biotherapeutics is expanding the curative potential of immunotherapies by dispatching its Flare platform to overcome solid tumors. solid tumors immunotherapy dispatch biotherapeutics https://portal.fis.tum.de/en/publications/monitoring-chemotherapy-and-radiotherapy-of-solid-tumors/ Monitoring chemotherapy and radiotherapy of solid tumors - Technical University of Munich solid tumors technical university monitoring chemotherapy radiotherapy https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2019-08451&r=1 A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors - NCI A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors a study solid tumors advanced nci https://www.cms.gov/medicare-coverage-database/view/nca.aspx?ncaid=218& NCA - Positron Emission Tomography (FDG) for Solid Tumors (CAG-00181R) Use this page to view details for NCA - Positron Emission Tomography (FDG) for Solid Tumors (CAG-00181R). positron emission tomography solid tumors nca fdg cag https://pubmed.ncbi.nlm.nih.gov/11510032/ Beyond pancreatic cancer: irinotecan and gemcitabine in solid tumors and hematologic malignancies Non-platinum combinations including gemcitabine and irinotecan (Gemzar; Eli Lilly and Company, Indianapolis, IN) for the management of a variety of... pancreatic cancer solid tumors beyond irinotecan https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2021-03566&r=1 Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors - NCI Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors in patients solid tumors study evaluate https://magazine.columbia.edu/article/new-immunotherapy-breakthrough-solid-tumors A New Immunotherapy Breakthrough for Solid Tumors | Columbia Magazine a new solid tumors immunotherapy breakthrough columbia https://tobias-lib.ub.uni-tuebingen.de/xmlui/handle/10900/42885 Animal models of extracranial pediatric solid tumors (Review) animal models solid tumors pediatric review https://bmcdev-e2b2a6gdfff3f6d0.uaenorth-01.azurewebsites.net/diseases/symptom-management-in-solid-tumors-and-hematologic-malignancies/ Symptom management in solid tumors and hematologic malignancies - Burjeel Medical City symptom management solid tumors hematologic malignancies https://www.techtransfer.nih.gov/tech/tab-4111 Cancer Vaccines against POTE for Treating Solid Tumors | Technology Transfer cancer vaccines solid tumors pote treating technology https://drive.google.com/file/d/1DikBM86tkkPxftLlet3z_DFBXh94tSIj/view?usp=sharing Program Solid Tumors Course Oslo April 2025.docx.pdf - Google Drive solid tumors program course oslo https://zucmanlab.com/ Functional genomics of solid tumors - FunGeST - functional genomics solid tumors https://researchconnect.buffalo.edu/en/publications/multicellular-immune-ecotypes-within-solid-tumors-predict-real-wo/ Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with... solid tumors https://www.wikidata.org/wiki/Q29618818 Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors - Wikidata scientific article (publication date: 30 October 1992) solid tumors comparative genomic hybridization molecular https://pmc.ncbi.nlm.nih.gov/articles/PMC8054411/ CAR-T cells and BiTEs in solid tumors: challenges and perspectives - PMC Chimeric antigen receptor (CAR)-modified T cells and BiTEs are both immunotherapies which redirect T cell specificity against a tumor-specific antigen through... car t cells solid tumors bites https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2023-06767 FOG-001 in Locally Advanced or Metastatic Solid Tumors - NCI FOG-001 in Locally Advanced or Metastatic Solid Tumors solid tumors fog locally advanced metastatic https://bibliographie.uni-tuebingen.de/xmlui/handle/10900/100631 Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL solid tumors inhibition nk reactivity https://www.cancer.gov/pediatric-adult-rare-tumor/naturalhistorystudyvideowhat What is the Natural History Study of Rare Solid Tumors? - NCI This video explains basic information about the Natural History Study of Rare Solid Tumors and why natural history studies are important in clinical research. what is the natural history study solid tumors https://www.fda.gov/about-fda/oncology-center-excellence/modeling-pediatric-solid-tumors-and-tumor-microenvironment Modeling Pediatric Solid Tumors and the Tumor Microenvironment | FDA Modeling Pediatric Solid Tumors and the Tumor Microenvironment solid tumors and the modeling pediatric microenvironment https://pubmed.ncbi.nlm.nih.gov/27349981/ Immune checkpoint inhibitor combinations in solid tumors: opportunities and challenges The emergence of immune 'checkpoint inhibitors' such as cytotoxic T-lymphocyte antigen 4 (CTLA-4) and programmed death receptor 1 (PD-1) has revolutionized... immune checkpoint solid tumors inhibitor combinations opportunities https://www.mdpi.com/journal/cancers/special_issues/PMST Cancers | Special Issue : Precision Medicine in Solid Tumors Cancers, an international, peer-reviewed Open Access journal. special issue precision medicine cancers solid tumors https://penntoday.upenn.edu/news/removing-barrier-surrounding-solid-tumors-clears-path-t-cells Removing the barrier surrounding solid tumors clears path for T cells | Penn Today Penn researchers uncover a new way to target solid tumors. Using CAR T cells to remove cancer-associated fibroblasts surrounding pancreatic tumors allows T... https://experts.colorado.edu/display/pubid_70114 Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors | CU... https://www.techtransfer.nih.gov/patent/e-118-2021-0-ca-01 Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors | Technology... single domain antibodies https://pubmed.ncbi.nlm.nih.gov/38886487/ Homeobox and Polycomb target gene methylation in human solid tumors DNA methylation is an epigenetic mark that plays an important role in defining cancer phenotypes, with global hypomethylation and focal hypermethylation at CpG... in human target gene methylation solid https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2025-04262&r=1 A Study of GSK5733584 in Combination With Anti-cancer Therapies for Advanced Solid Tumors - NCI A Study of GSK5733584 in Combination With Anti-cancer Therapies for Advanced Solid Tumors https://www.immunologie.med.uni-muenchen.de/news/baeuerle_u_wesche/index.html T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities -... https://researchconnect.buffalo.edu/en/publications/chemophototherapy-an-emerging-treatment-option-for-solid-tumors/ Chemophototherapy: An Emerging Treatment Option for Solid Tumors - SUNY University at Buffalo https://scholarworks.indianapolis.iu.edu/items/bc74068c-013f-41b2-9c1d-d8b095629be7 KRAS G12C Inhibition with Sotorasib in Advanced Solid Tumors Background: No therapies for targeting KRAS mutations in cancer have been approved. The KRAS p.G12C mutation occurs in 13% of non-small-cell lung cancers... kras inhibition sotorasib advanced solid https://www.techtransfer.nih.gov/patent/e-185-2019-0-us-01 High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors | Technology... https://pubmed.ncbi.nlm.nih.gov/28035748/ A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors The combination of these AKT and mTOR inhibitors was safe and feasible in patients with recurrent/refractory pediatric solid tumors. phase i study https://pmc.ncbi.nlm.nih.gov/articles/PMC5852245/ Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug... For over six decades reductionist approaches to cancer chemotherapies including recent immunotherapy for solid tumors produced outcome failure-rates of 90%... https://scholars.duke.edu/publication/1476534 Scholars@Duke publication: Larotrectinib: A Targeted Therapy for Solid Tumors. targeted therapy scholars duke publication solid https://cordis.europa.eu/programme/id/FP6_LSH-2004-1.2.2-1 New Screening techniques and strategies in the early diagnosis of solid tumors | Programme | FP6 |... https://scholars.duke.edu/publication/1690201 Scholars@Duke publication: Intracranial metastases from solid tumors: Call to action and consensus... https://www.cirm.ca.gov/cirm-trial/ace2016-in-adult-subjects-with-locally-advanced-or-metastatic-solid-tumors-expressing-epidermal-growth-factor-receptor-egfr-2/ ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal... https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.655781/full Frontiers | Enhanced Drug Delivery to Solid Tumors via Drug-Loaded Nanocarriers: An Image-Based... Objective: Nano-sized drug delivery systems (NSDDSs) offer a promising therapeutic technology with sufficient biocompatibility, stability, and drug-loading r... https://clinicaltrials.med.nyu.edu/cancer/clinicaltrial/1854/phase-12-study-ly3537982/?section=elg&qd=32738160 A Phase 1/2 Study of LY3537982 in Patients with KRAS G12C-Mutant Advanced Solid Tumors | NYU... New life-saving treatments for Advanced Solid Tumors in clinical trial on A Phase 1/2 Study of LY3537982 in Patients with KRAS G12C-Mutant Advanced Solid Tumors https://pubmed.ncbi.nlm.nih.gov/39900573/ Harnessing macrophage-drug conjugates for allogeneic cell-based therapy of solid tumors via the... Treatment of solid tumors remains challenging and therapeutic strategies require continuous development. Tumor-infiltrating macrophages play a pivotal role in... https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1484303/full Frontiers | Aging impairs CD8 T cell responses in adoptive T-cell therapy against solid tumors Age-associated defects in T cell-mediated immunity can increase the risk of cancers, but how aging influences adoptive T-cell therapy (ACT) for cancers remai... https://pubmed.ncbi.nlm.nih.gov/37331529/ Metastatic solid tumors to the testis: a clinicopathologic evaluation of 157 cases from an... To elucidate the spectrum of metastatic solid tumors to the testis and their clinicopathologic features. The databases and files of 26 pathology departments... https://adisinsight.springer.com/trials/700391231?error=cookies_not_supported&code=28ffe46c-7374-4945-844e-2bfc65f802d1 A clinical study of T cell receptor engineered T cell therapy in solid tumors. - AdisInsight This is a clinical study of T cell receptor engineered T cell therapy in solid tumors. https://pure.psu.edu/en/publications/whats-new-in-molecular-genetic-pathology-2021-solid-tumors-and-ng/ What's new in molecular genetic pathology 2021: Solid tumors and NGS panel selection - Penn State https://www.benzinga.com/general/biotech/21/07/22104018/adagene-to-test-its-anti-ctla-4-monoclonal-antibodies-in-combination-with-keytruda-in-solid-tumor Adagene To Test Its Anti-CTLA-4 Monoclonal Antibodies In Combination With Keytruda In Solid Tumors... https://dspace.rpi.edu/items/f2062f7f-3504-426f-b98a-68395dc9b630 Enzyme-catalyzed self-propelling particles : applications for drug delivery to solid tumors We report the design and synthesis of silica Janus motors via the Pickering emulsion method, using a naturally occurring enzyme, catalase, which catalyzes the... applications for https://www.techtransfer.nih.gov/patent/e-192-2020-1-us-01 USE OF AGONISTS TO AUGMENT CART FUNCTION IN SOLID TUMORS | Technology Transfer https://www.techtransfer.nih.gov/patent/e-185-2019-0-cn-05 High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors | Technology... https://www.bio4t2.com/ Bio4t2 clinical stage company CAR-T for solid tumors Bio4t2, clinical stage company uses PrismCore platform to genetically modify T cells to express CARs tuned to recognize self-antigens overexpressed on solid... company car clinical stage solid tumors https://portal.fis.tum.de/en/publications/in-response-to-serum-tumor-marker-use-in-patients-with-advanced-s/ In response to "serum tumor marker use in patients with advanced solid tumors" - Technical... https://cordis.europa.eu/project/id/949667/pl Senolytic CAR T cells as novel therapeutic concept for solid tumors and senescence-associated... The adoptive transfer of T cells expressing CD19-directed chimeric antigen receptors (CARs) has yielded remarkable efficacy in patients with hematological... https://experts.arizona.edu/en/publications/pilot-phase-ii-study-of-the-combination-of-lenvatinib-l-and-eribu/ Pilot phase II study of the combination of lenvatinib (L) and eribulin (E) in advanced solid tumors... https://pubmed.ncbi.nlm.nih.gov/23118781/ Invariant NKT cells as novel targets for immunotherapy in solid tumors Natural killer T (NKT) cells are a small population of lymphocytes that possess characteristics of both innate and adaptive immune cells. They are uniquely... invariant nkt cells novel https://www.techtransfer.nih.gov/patent/e-040-2019-0-us-07 Cross Species Single Domain Antibodies Targeting Mesothelin For Treating Solid Tumors | Technology... single domain antibodies cross species https://www.news-medical.net/whitepaper/20221116/mRNA-technology-to-treat-a-variety-of-solid-tumors.aspx mRNA technology to treat a variety of solid tumors Nov 16, 2022 - This article assesses the efficacy and persistence of a self-amplified mRNA vaccine system for treating advanced metastatic solid tumors. mrna technology treat variety solid tumors https://uwspace.uwaterloo.ca/items/36ebcf4d-987d-4c91-8cdc-0ab2ab567ca9 Dynamic Modeling of Drug Transport in Solid Tumors and Optimal Chemotherapy Regimen One of the most common therapies for treatment of cancer patients is chemotherapy. Therapeutic agents (drugs) can kill cancer cells by damaging their DNA and... dynamic modeling https://pubmed.ncbi.nlm.nih.gov/26314551/ The distribution of BRAF gene fusions in solid tumors and response to targeted therapy Although the BRAF V600E base substitution is an approved target for the BRAF inhibitors in melanoma, BRAF gene fusions have not been investigated as anticancer... https://dukespace.lib.duke.edu/items/49dc0ad2-f36c-4539-8164-95ee4d4343be Modelling the contributing factors of hypoxic fractions in human solid tumors in human modelling contributing factors https://cancer-insights.asu.edu/2018/05/the-fluid-phase-of-solid-tumors-how-does-cancer-spread/ The Fluid Phase of Solid Tumors: How does cancer spread? | Arizona Cancer Evolution Center https://pubchem.ncbi.nlm.nih.gov/patent/US-2002187130-A1 Adjuvant immune therapy in the treatment of solid tumors through modulation of signaling pathways... US-2002187130-A1 chemical patent summary. https://www.techtransfer.nih.gov/patent/e-185-2019-0-jp-07 High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors | Technology... https://www.businesswire.com/news/home/20260331379917/en/BostonGene-RNA-Transcriptome-Profiling-Reveals-New-ADC-Targets-in-Advanced-Solid-Tumors BostonGene RNA Transcriptome Profiling Reveals New ADC Targets in Advanced Solid Tumors BostonGene, developer of the leading AI foundation model for tumor and immune biology, announced results from the FEASY study in collaboration with The Unive... transcriptome profiling https://cordis.europa.eu/project/id/101078722 Decoding Requirements for Infiltration of T ceLLs into solid tumors | DRILL | Project | Fact Sheet... Cancer immunotherapies that leverage T cell activities are transforming cancer treatment. Currently, enormous effort has been devoted to empowering T cells to... https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT03213665&r=1 Tazemetostat in Treating Patients with Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin... Tazemetostat in Treating Patients with Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders with EZH2, SMARCB1, or... https://cordis.europa.eu/project/id/949667/results/de Senolytic CAR T cells as novel therapeutic concept for solid tumors and senescence-associated... Deliverables, publications, datasets, software, exploitable results https://www.cruk.cam.ac.uk/publications/phase-i-study-of-everolimus-in-pediatric-patients-with-refractory-solid-tumors/ Phase I study of everolimus in pediatric patients with refractory solid tumors. - Cancer Research... Authors: M Fouladi, F Laningham, J Wu, MA O'Shaughnessy, K Molina, A Broniscer, SL Spunt, I Luckett, CF Stewart, PJ Houghton, RJ Gilbertson, WL Furman Journal... phase i study https://www.news-medical.net/news/20241007/Innovative-immunotherapy-harnesses-natural-killer-T-cells-to-combat-solid-tumors.aspx Innovative immunotherapy harnesses natural killer T cells to combat solid tumors Oct 7, 2024 - In the fight against cancer, chimeric antigen receptor T cell (CAR-T) therapy has achieved notable success in treating blood cancers. However, it has been... t cells combat solid innovative immunotherapy harnesses https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=Y&ncaid=263 NCA - Positron Emission Tomography (FDG) for Solid Tumors (CAG-00181R4) - Proposed Decision Memo Use this page to view details for the Proposed Decision Memo for Positron Emission Tomography (FDG) for Solid Tumors (CAG-00181R4). positron emission tomography https://experts.arizona.edu/en/publications/treatment-of-recurrent-and-refractory-pediatric-solid-tumors-with/ Treatment of recurrent and refractory pediatric solid tumors with high-dose busulfan and... https://clinicaltrials.med.nyu.edu/cancer/clinicaltrial/1854/phase-12-study-ly3537982/?qd=39522919 A Phase 1/2 Study of LY3537982 in Patients with KRAS G12C-Mutant Advanced Solid Tumors | NYU... New life-saving treatments for Advanced Solid Tumors in clinical trial on A Phase 1/2 Study of LY3537982 in Patients with KRAS G12C-Mutant Advanced Solid Tumors https://pmc.ncbi.nlm.nih.gov/articles/PMC12487835/ Tumor Treating Fields: An Innovative Therapy for Glioblastoma and Other Solid Tumors - PMC Tumor Treating Fields (TTFields) therapy specifically disrupts cellular processes necessary for cancer cell viability and tumor progression through the... https://publikationen.uni-tuebingen.de/xmlui/handle/10900/53563 Surgical treatment of lung metastases in patients with embryonal pediatric solid tumors: an update https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=57905 Article - Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors (A57905) Use this page to view details for the Local Coverage Article for Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors. billing and coding next generation sequencing https://www.cms.gov/medicare-coverage-database/view/ncacal-public-comments.aspx?NCAId=218&ExpandComments=n&ver=15&NcaName=Positron+Emission+Tomography+(FDG)+for+Solid+Tumors+(1st+Recon)&bc=BEAAAAAAEAAA&&fromdb=true NCA - Positron Emission Tomography (FDG) for Solid Tumors (CAG-00181R) - View Public Comments Use this page to nca - positron emission tomography (fdg) for solid tumors (cag-00181r) - view public comments. positron emission tomography https://cordis.europa.eu/project/id/101078722/de Decoding Requirements for Infiltration of T ceLLs into solid tumors | DRILL | Projekt |... Cancer immunotherapies that leverage T cell activities are transforming cancer treatment. Currently, enormous effort has been devoted to empowering T cells to... t cells https://www.news-medical.net/news/20250905/New-drug-candidate-STF-1623-activates-innate-immunity-in-solid-tumors.aspx New drug candidate STF 1623 activates innate immunity in solid tumors Sep 6, 2025 - Cancer immunotherapy, which primes the body's immune system to fight off tumors, has historically focused on harnessing T cells' natural ability to recognize... new drug innate immunity candidate stf https://pubmed.ncbi.nlm.nih.gov/19934295/ Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response... Systematic criteria, designated immune-related response criteria, were defined in an attempt to capture additional response patterns observed with immune... https://cancer.osu.edu/for-patients-and-caregivers/learn-about-cancers-and-treatments/innovation-at-the-james/clinical-trials/find-a-clinical-trial/a-phase-i-study-of-ff10850-topotecan-liposome A Phase I Study of FF-10850, Topotecan Liposome Injection, in Advanced Solid Tumors Including... A Phase I Study of FF-10850, Topotecan Liposome Injection, in Advanced Solid Tumors Including Ovarian and Cervical Carcinomas, Sarcomas, and Neuroendocrine... https://www.techtransfer.nih.gov/patent/e-118-2021-0-pct-02 Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors | Technology... single domain antibodies https://www.techtransfer.nih.gov/patent/e-024-2009-0-ep-05 GENE SIGNATURE FOR PREDICTING PROGNOSIS OF PATIENTS WITH SOLID TUMORS | Technology Transfer https://scholars.duke.edu/publication/1502914 Scholars@Duke publication: The microenvironment of brain metastases from solid tumors. brain metastases scholars duke publication microenvironment https://clinicaltrials.med.nyu.edu/cancer/clinicaltrial/972/phase-12-multiple-expansion/?qd=33953735 A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with... New life-saving treatments for Advanced Solid Tumors in clinical trial on A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced...